Resultado da Busca
18 de mai. de 2022 · Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term ...
18 de mai. de 2022 · It said he is projected to be released from federal custody on Sept. 14. In a Facebook post Wednesday, Shkreli, who became known as "pharma bro" for taking a rare lifesaving drug and raising its ...
- 24 seg
- Rob Wile
26 de jul. de 2022 · Martin Shkreli foi condenado em 2017 por fraude de valores mobiliários pelo período em que comandou os fundos MSMB Capital e MSMB Healthcare. Além disso, o ex-executivo respondeu a um processo por aumentar em 5.000% o preço de Daraprim, um medicamento prescrito para pacientes com aids e câncer, após Turing Pharmaceuticals – empresa em que era o CEO – obter a patente do remédio.
マーティン・シュクレリ (英語: Martin Shkreli 、 [ˈ ʃ k r ɛ l i] 、1982年または1983年-) は、アメリカ合衆国の起業家 、製薬会社重役 。
9 de mar. de 2018 · Martin Shkreli, the former drug company executive who made headlines by jacking up the price of a lifesaving drug before he was found guilty of defrauding investors, was sentenced to 7 years and a ...
4 de fev. de 2016 · Former Turing Pharmaceuticals CEO Martin Shkreli testifies before the House Oversight Committee hearing on drug price hikes, invoking the Fifth Amendment.
- 10 min
- 981,2K
- CNBC
23 de jan. de 2024 · Today, the United States Court of Appeals for the Second Circuit affirmed a district court ruling which ordered “Pharma Bro” Martin Shkreli to face a lifetime ban from participating in the pharmaceutical industry and found Shkreli liable for $64.6 million in disgorgement for his role in orchestrating an illegal anticompetitive scheme.
